Clinical trial
Observational Cohort Study of TachoSil (TC-018-IN)
NCT00285623 · Nycomed, Industry · Completed
Key facts
| NCT number | NCT00285623 |
|---|---|
| Title | Observational Cohort Study of TachoSil (TC-018-IN) |
| Official title | An Non-interventional, Prospective, Non-controlled Study of the Use of TachoSil in Supportive Treatment in Surgery for Improvement of Haemostasis Where Standard Techniques Are Insufficient. |
| Lead sponsor | Nycomed, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Blood Loss, Surgical |
| Intervention type | Drug |
| Interventions | Fibrinogen (human) + thrombin (human) (TachoSil) |
| Enrollment | 3,000 |
| Start date | Dec 1, 2005 |
| Primary completion | Apr 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Feb 2, 2006 |
| Last update posted | May 7, 2012 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: